An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy [2]

Journal of Clinical Psychopharmacology

Volumn 23, Issue 2, 2003, Pages 207-209

  Markovitz, Paul J ^a   Wagner, Susan ^a  

^a Mood and Anxiety Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MODAFINIL; NEFAZODONE; PAROXETINE; PSYCHOSTIMULANT AGENT; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; LETTER; MALE; NAUSEA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0037380690     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200304000-00017     Document Type: Letter

References (9)

1. Anderson I, Tomenson B. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. Psychopharmacol (Oxford) 1994;8:238-49.
2. Silverstone PH, Ravindran A, for Venlafaxine XR 360 Study Group. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. J Clin Psychiatry 1999;60:22-8.
3. Feighner JP, Gardner EA, Johnston JA, et al. Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry 1991;52:329-35.
4. Lôo H, Saiz-Ruiz J, Costa e Silva JA, et al. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. J Affect Disord 1999;56:109-18.
5. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-41.
6. Fawcett J, Kravitz HM, Zajecka JM, Schaff MR. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharmacol 1991;11:127-32.
7. American Hospital Formulary Service Drug Information. Medscape DrugInfo. Available at: http://www.promini.medscape.com/ drugdb/search.asp. Accessed January 12, 2001.
8. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999;22:757-65.
9. Menza MA, Kaufman KR, Castellanos AM. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000;61:378-81.